Blueprint Medicines
BPMC
Reported
Wednesday, October 30
Q3 2024 Earnings
| (USD) | Expected | Reported | Surprise $ | Surprise % |
|---|---|---|---|---|
| EPS | -0.96 | -0.89 | 0.07 | 7.29% |
| Revenue | 127M | 128M | 1.15M | 0.91% |
WhatIF - Earnings
EPS Beat Expectations by $0.07
Blueprint Medicines (BPMC:NASDAQ) has never beaten EPS by this much before
There’s a first time for everything